SKIN5 Aug 2019 15:41
* Two CBD test contracts have been signed since the beginning of the year with eight contracts currently under negotiation;
*Fully funded - The growth of the Company has been so well supported and received by the market that all corporate activity has been achieved, funding in place to accommodate the continued growth.
* meeting its objective of increasing the average revenue per client as it evolves into a multiple revenue stream product and services company
*Expanding Laboratory and office space.
* Four Blue-Chip (US and EU) client agreements signed
* "The objective of disposing of non-performing subsidiaries and incorporating fully integrated teams of skilled personnel, across multiple subsidiaries, with a single focus of increasing revenue per-existing client and closing bigger deals with new clients has been met,"
* Company moving foward at a rapid pace.
* 'Labskin’s Fibrin Gel matrix is the only commercially available laboratory-grown full thickness human skin test platform that creates new collagen production and shows the impact on your skin’s microflora balance of cosmetic and skin care products.
Specifically developed animal-cruelty-free test solution to host harmful skin bacteria which
allows the introduction of toxins, bacteria, viruses, and other foreign substances that trigger
an immune response.'
* Current price is a gift.